TABLE 2:
Treatment groups | Baseline (mm) | Vasospasm (mm) | Treatment (mm) |
---|---|---|---|
ia nimodipine | 0.70 ± 0.03 | 0.40 ± 0.06* | 0.62 ± 0.02†§ |
it nimodipine | 0.83 ± 0.03 | 0.42 ± 0.06* | 0.51 ± 0.06† |
ia vehicle | 0.67 ± 0.02 | 0.48 ± 0.01* | 0.48 ± 0.01 |
it vehicle | 0.59 ± 0.01 | 0.47 ± 0.01* | 0.41 ± 0.05 |
ia papaverine | 0.60 ± 0.02 | 0.43 ± 0.03* | 0.49 ± 0.03† |
All values were derived from n=5 experiments except for IT vehicle group where n=2 experiments were applied. Data were expressed as mean ± SEM.
Statistically significant from baseline values (P < .05).
Statistically significant from values obtained during vasospasm (P < .05).
Statistically significant from values obtained in either IT nimodipine or IA papaverine treatments.